All News

A long-term trial shows oral orforglipron boosts A1C and weight loss with reassuring cardiovascular safety and simpler dosing for type 2 diabetes.

Practical pharmacy wound care tips include choosing modern dressings, spotting infection red flags, and knowing when to refer.

Pharmacists optimize insulin therapy, including basal and bolus dosing, missed-dose tips, continuous glucose monitoring insights, and affordability.

New research shows older adults vaccinate more when confident navigating their health care.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.

New 2026 guidance backs long-term obesity drugs, spotlighting GLP-1 benefits, side effects, and off-label risks pharmacists must navigate.

Through the lens of changes in medication adherence, researchers assessed differences in CVD-related emergency department visits and total cost of care.

The most common mistake pharmacists can make when promoting their new clinical service is not marketing it.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

Community pharmacists deliver fast wound assessment, OTC guidance, and prevention tips, supporting safe healing when clinics are closed and care feels urgent.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

Community pharmacy workflows can support medical billing and new clinical services, empowering technicians and freeing pharmacists for patient care.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Chad Worz, PharmD, BCGP, FASCP, and Jeffrey Hogan, present on the implications behind major PBM reform signed in February and how the reimbursement landscape is expected to shift.

Non-high-density lipoprotein cholesterol matters in type 2 diabetes care and can be managed with statins, combination therapy, and omega‑3s.

Matt Sample and Neal Cooper join to discuss the beginning stages of the FDA’s 7-year rollout of new NDCs for prescription drugs.

Meta-analysis shows PCV13 followed by PPSV23 boosts pneumococcal immunity in seniors without added adverse effects.

This decision marks a historic milestone as sparsentan becomes the first and only medication specifically approved for this rare and devastating condition.

Community pharmacists guide minor wound care—clean, protect, and monitor—spot infection risks, and refer serious injuries quickly to prevent complications.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

Pharmacists can help cut prescription abandonment with proactive benefit checks, prior authorization help, and copay assistance.

Pharmacists can help to choose the right ingredient and avoid drug interactions for OTC relief for gas, motion sickness, nausea, and heartburn.

FDA-approved atrasentan cuts proteinuria in IgA nephropathy, with ALIGN trial results, safety insights, and dosing cautions.

Tentative FDA nod for generic semaglutide signals more glucagon-like peptide-1 access, easing pharmacy hurdles and curbing risky compounded alternatives.

Meta-analysis shows CGM lowers HbA1c and hypoglycemia in insulin-treated type 2 diabetes, while pharmacists tackle training, costs, and skin issues.

Researchers assess medication adherence across initial combination therapy users during their first year of type 2 diabetes treatment.